FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk

European Journal of Nutrition

Volumn 56, Issue 3, 2017, Pages 1293-1301

  Sprenger, Norbert ^a   Odenwald, Hannah ^a,b,e   Kukkonen, Anna Kaarina ^c   Kuitunen, Mikael ^d   Savilahti, Erkki ^d   Kunz, Clemens ^b  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^e Nestlé Health Sciences   (Switzerland)

Author keywords

Allergy; Breast feeding; Human milk oligosaccharides; Mode of delivery

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; IMMUNOGLOBULIN E; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; 2'-FUCOSYLLACTOSE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; TRISACCHARIDE;

ALLERGIC DISEASE; ARTICLE; BREAST FEEDING; BREAST MILK; CHILD; CONTROLLED STUDY; ECZEMA; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER; OBSTETRIC DELIVERY; PRESCHOOL CHILD; PRICK TEST; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIZATION; SEX DIFFERENCE; BLOOD; CHEMISTRY; DOUBLE BLIND PROCEDURE; FOLLOW UP; GENETIC DISEASES, INBORN; GENETICS; HYPERSENSITIVITY; INCIDENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ECZEMA; FEMALE; FOLLOW-UP STUDIES; FUCOSYLTRANSFERASES; GENETIC DISEASES, INBORN; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INCIDENCE; MALE; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; RISK FACTORS; TRISACCHARIDES;

EID: 84959090021     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-016-1180-6     Document Type: Article

References (34)

1. Legatzki A, Rösler B, von Mutius ME (2014) Microbiome diversity and asthma and allergy risk. Curr Allergy Asthma Rep 14:466
2. Macfarlane GT, Macfarlane LE (2009) Acquisition, evolution and maintenance of the normal gut microbiota. Dig Dis 27(Suppl 1):90–98
3. Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69:1035S–1045S
4. Nauta AJ, Ben AK, Knol J, Garssen J, van der Beek EM (2013) Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr 98:586S–593S
5. Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD (2012) Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 3:203–220
6. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159–166
7. Kunz C, Rudloff S, Baier W, Klein N, Strobel S (2000) Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20:699–722
8. Jantscher-Krenn E, Bode L (2012) Human milk oligosaccharides and their potential benefits for the breast-fed neonate. Minerva Pediatr 64:83–99
9. Stahl B, Thurl S, Henker J, Siegel M, Finke B, Sawatzki G (2001) Detection of four human milk groups with respect to Lewis-blood-group-dependent oligosaccharides by serologic and chromatographic analysis. Adv Exp Med Biol 501:299–306
10. Blank D, Dotz V, Geyer R, Kunz C (2012) Human milk oligosaccharides and Lewis blood group: individual high-throughput sample profiling to enhance conclusions from functional studies. Adv Nutr 3:440S–449S
11. Erney RM, Malone WT, Skelding MB, Marcon AA, Kleman-Leyer KM, O’Ryan ML, Ruiz-Palacios G, Hilty MD, Pickering LK, Prieto PA (2000) Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr 30:181–192
12. Castanys-Munoz E, Martin MJ, Prieto PA (2013) 2′-fucosyllactose: an abundant, genetically determined soluble glycan present in human milk. Nutr Rev 71:773–789
13. Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, Van Tassell ML, Miller MJ, Jin YS, German JB, Lebrilla CB, Mills DA (2015) Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3:13
14. Newburg DS, Ruiz-Palacios GM, Morrow AL (2005) Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25:37–58
15. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS (2005) Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135:1304–1307
16. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, Pickering LK, Newburg DS (2001) Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11:365–372
17. Yu ZT, Chen C, Newburg DS (2013) Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 23:1281–1292
18. Yu ZT, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, Newburg DS (2013) The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23:169–177
19. Castillo-Court Han S, Lee S, Mian FM, Buck R, Forsythe P (2015) Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy 70:1091–1102
20. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129–134
21. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC (2012) Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 129:434–440
22. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi PV, Robins-Browne RM, Tang ML (2012) Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 23:674–681
23. Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, Fleet JC, Kortagere S, Mukherjee P, Fasano A, Le VJ, Nicholson JK, Dumas ME, Khanna KM, Mani S (2014) Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like Receptor 4. Immunity 41:296–310
24. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M (2007) Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 119:192–198
25. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E (2009) Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 123:335–341
26. Blank D, Gebhardt S, Maass K, Lochnit G, Dotz V, Blank J, Geyer R, Kunz C (2011) High-throughput mass finger printing and Lewis blood group assignment of human milk oligosaccharides. Anal Bioanal Chem 401:2495–2510
27. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Meinzen-Derr J, Guerrero ML, Morrow AL (2004) Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 14:253–263
28. Negele K, Heinrich J, Borte M, von Berg A, Schaaf B, Lehmann I, Wichmann HE, Bolte G (2004) Mode of delivery and development of atopic disease during the first 2 years of life. Pediatr Allergy Immunol 15:48–54
29. Penders J, Gerhold K, Stobberingh EE, Thijs C, Zimmermann K, Lau S, Hamelmann E (2013) Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 132:601–607
30. Chichlowski M, De LG, German JB, Raybould HE, Mills DA (2012) Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr 55:321–327
31. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van LM, Madsen KL (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295:G1025–G1034
32. Ganguli K, Meng D, Rautava S, Lu L, Walker WA, Nanthakumar N (2013) Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 304:G132–G141
33. Castillo-Courtade L, Han S, Lee S, Mian FM, Buck R, Forsythe P (2015) Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy 70:1091–1102
34. Maroni L, van de Graaf SF, Hohenester SD, Oude Elferink RP, Beuers U (2014) Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn’s disease—a comprehensive review. Clin Rev Allergy Immunol 48:182–191